Exit barriers are low (Pharma industry)

Last Updated by Anonymous | Update This Page Flag this page Delete This Page

rating: 0+x

When exit barriers are low, weak firms are more likely to leave the market, which will increase the profits for the remaining firms. Low exit barriers are a positive for Pharma industry. … This qualitative factor will lead to a decrease in costs. "Exit barriers are low (Pharma industry)" is a difficult qualitative factor to defend, so competing institutions will have an easy time overcoming it. "Exit barriers are low (Pharma industry)" will have a long-term negative impact on this entity, which subtracts from the entity's value.

Affected Investments